Literature DB >> 15378353

Significance of isolated tumor cells in lymph nodes among gastric cancer patients.

Olaf Horstmann1, Laszlo Füzesi, Peter M Markus, Carola Werner, Heinz Becker.   

Abstract

PURPOSE: To determine the frequency and prognostic impact of isolated tumor cells (ITC) in regional lymph nodes judged to be tumor free in conventional histopathology among gastric cancer patients.
METHODS: Among 161 patients who underwent gastrectomy and D2-lymphadenectomy, 56 were staged pN0(35%). Archival paraffin blocks of 1148 resected regional lymph nodes of those pN0 patients were reevaluated for ITC using monoclonal antibody Ber-EP4. Patients with and without ITC were compared with regard to the distribution of various clinicopathological factors. Prognostic impact of ITC was tested in uni- and multivariate analysis.
RESULTS: Of 56 pN0 patients, 33 (59%) exhibited single Ber-Ep4 immunoreactive cells or small cell clusters in at least one lymph node. The occurrence of ITC was not dependent on other clinicopathological factors. ITC impaired patients' prognoses significantly in uni- as well as multivariate analyses [estimated 5-year survival rate: 82% for pN0((i-))vs 58% for pN0((i+))(p = 0.059) and 15% for pN1/2 (p = 0.0005 and p < 0.0001, respectively)].
CONCLUSION: ITC are a frequent event in apparently tumor-free lymph nodes of gastric cancer patients and are overlooked by conventional histopathology. They are encountered even in limited stages of disease and impair patients' prognoses. This should be borne in mind when advocating local resection for early gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15378353     DOI: 10.1007/s00432-004-0609-0

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  38 in total

1.  Identification of occult micrometastases in patients with early gastric cancer using anti-cytokeratin monoclonal antibodies.

Authors:  L Saragoni; M Gaudio; P Morgagni; S Folli; F Bazzocchi; E Scarpi; A Saragoni
Journal:  Oncol Rep       Date:  2000 May-Jun       Impact factor: 3.906

2.  Occurrence and prognostic implications of micrometastases in lymph nodes from patients with submucosal gastric carcinoma.

Authors:  Hong-Jo Choi; Yun-Ki Kim; Young-Hoon Kim; Sang-Soon Kim; Sook-Hee Hong
Journal:  Ann Surg Oncol       Date:  2002 Jan-Feb       Impact factor: 5.344

3.  Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases.

Authors:  J R Siewert; R Kestlmeier; R Busch; K Böttcher; J D Roder; J Müller; C Fellbaum; H Höfler
Journal:  Br J Surg       Date:  1996-08       Impact factor: 6.939

4.  Lymph node micrometastases in early gastric cancer and their impact on prognosis.

Authors:  Paolo Morgagni; Luca Saragoni; Emanuela Scarpi; Pier Sante Zattini; Alberto Zaccaroni; Diana Morgagni; Francesca Bazzocchi
Journal:  World J Surg       Date:  2003-04-28       Impact factor: 3.352

5.  Early lymphatic tumor cell dissemination in pancreatic cancer: frequency and prognostic significance.

Authors:  S B Hosch; W T Knoefel; S Metz; N Stoecklein; A Niendorf; C E Broelsch; J R Izbicki
Journal:  Pancreas       Date:  1997-08       Impact factor: 3.327

6.  Clinical significance of occult micrometastasis lymph nodes from patients with early gastric cancer who died of recurrence.

Authors:  Y Maehara; T Oshiro; K Endo; H Baba; S Oda; Y Ichiyoshi; S Kohnoe; K Sugimachi
Journal:  Surgery       Date:  1996-04       Impact factor: 3.982

7.  Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies.

Authors:  R Moll; A Löwe; J Laufer; W W Franke
Journal:  Am J Pathol       Date:  1992-02       Impact factor: 4.307

8.  Lymph node micrometastases in early gastric carcinoma alone inadequately reflect the new model of metastatic development.

Authors:  J Stachura; M Zembala; J Heitzman; M Korabiowska; A Schauer
Journal:  Pol J Pathol       Date:  1998       Impact factor: 1.072

9.  Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow.

Authors:  K Pantel; G Schlimok; M Angstwurm; D Weckermann; W Schmaus; H Gath; B Passlick; J R Izbicki; G Riethmüller
Journal:  J Hematother       Date:  1994

10.  Distribution of lymph node metastasis including micrometastasis in gastric cancer with submucosal invasion.

Authors:  Hiroshi Higashi; Shoji Natsugoe; Sumiya Ishigami; Yoshikazu Uenosono; Masataka Matsumoto; Akihiro Nakajo; Futoshi Miyazono; Shuichi Hokita; Sonshin Takao; Takashi Aikou
Journal:  World J Surg       Date:  2003-04       Impact factor: 3.352

View more
  8 in total

Review 1.  [Minimal residual tumor in gastrointestinal carcinoma. Relevance to prognosis and oncologic surgical consequences].

Authors:  S Gretschel; A Bembenek; T Schulze; W Kemmner; P M Schlag
Journal:  Chirurg       Date:  2006-12       Impact factor: 0.955

2.  Occult Tumour Cells in Lymph Nodes from Gastric Cancer Patients: Should Isolated Tumour Cells Also Be Considered?

Authors:  A Tavares; X Wen; J Maciel; F Carneiro; M Dinis-Ribeiro
Journal:  Ann Surg Oncol       Date:  2020-05-04       Impact factor: 5.344

3.  Auxiliary diagnosis of lymph node metastasis in early gastric cancer using quantitative evaluation of sentinel node radioactivity.

Authors:  Satoshi Kamiya; Hiroya Takeuchi; Tadaki Nakahara; Masahiro Niihara; Rieko Nakamura; Tsunehiro Takahashi; Norihito Wada; Hirofumi Kawakubo; Yoshiro Saikawa; Tai Omori; Koji Murakami; Yuko Kitagawa
Journal:  Gastric Cancer       Date:  2015-11-30       Impact factor: 7.370

4.  [Significance of occult lymphatic tumor spread in pancreatic cancer].

Authors:  C Milsmann; L Füzesi; C Werner; H Becker; O Horstmann
Journal:  Chirurg       Date:  2005-11       Impact factor: 0.955

5.  The prognostic significance of isolated tumor cells in the lymph nodes of gastric cancer patients.

Authors:  Takeo Fukagawa; Mitsuru Sasako; Seiji Ito; Hayao Nakanishi; Hisae Iinuma; Shoji Natsugoe; Hitoshi Katai; Tadakazu Shimoda
Journal:  Gastric Cancer       Date:  2010-09-05       Impact factor: 7.370

6.  Deep neural network trained on gigapixel images improves lymph node metastasis detection in clinical settings.

Authors:  Shih-Chiang Huang; Chi-Chung Chen; Jui Lan; Tsan-Yu Hsieh; Huei-Chieh Chuang; Meng-Yao Chien; Tao-Sheng Ou; Kuang-Hua Chen; Ren-Chin Wu; Yu-Jen Liu; Chi-Tung Cheng; Yu-Jen Huang; Liang-Wei Tao; An-Fong Hwu; I-Chieh Lin; Shih-Hao Hung; Chao-Yuan Yeh; Tse-Ching Chen
Journal:  Nat Commun       Date:  2022-06-10       Impact factor: 17.694

7.  Morphological and immunohistochemical characterization of isolated tumor cells by p53 status in gastrointestinal tumors.

Authors:  C Milsmann; L Füzesi; E Heinmöller; P Krause; C Werner; H Becker; O Horstmann
Journal:  Langenbecks Arch Surg       Date:  2007-09-18       Impact factor: 3.445

8.  New evidence guiding extent of lymphadenectomy for esophagogastric junction tumor: Application of Ber-Ep4 Joint with CD44v6 staining on the detection of lower mediastinal lymph node micrometastasis and survival analysis.

Authors:  Bin Zheng; Chen-Hui Ni; Hao Chen; Wei-Dong Wu; Zhao-Hui Guo; Yong Zhu; Wei Zheng; Chun Chen
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.